A Phase 2, Double-blind Study of S-005151 in Patients with Acute Ischemic Stroke

SHIONOGI & CO., LTD.0 个研究点目标入组 150 人开始时间: 2019年9月18日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•Main Inclusion Criteria
•- Patients diagnosed with supratentorial ischemic stroke on magnetic resonance imaging (MRI)
•- Patients who can be enrolled within 24 hours from 4.5 hours after the onset of ischemic stroke
•- Patients with neurologic signs corresponding to 8-22 on the National Institute of Health Stroke Scale (NIHSS) score and who have not experienced a rapid change in neurologic signs within 30 minutes before enrollment

•Main Exclusion Criteria
•- Patients with a disability corresponding to mRS score of >=2 before the onset of ischemic stroke
•- Patients who have undergone thrombolysis or intravascular recanalization therapy within 90 days before obtaining informed consent.
•- Patients with a history of stroke or intracranial hemorrhage that caused neurological events within 90 days before obtaining informed consent.
•- Patients diagnosed with a transient ischemic attack
•- Patients who cannot have MRI

发起方